SOURCE: Equity Leader Inc.

February 22, 2012 09:00 ET

Conditions of Growth, Economic Analysis - Research Report on Saks Inc and Eli Lilly & Co.

HONG KONG--(Marketwire - Feb 22, 2012) - Today, introduced research coverage of Saks Inc (NYSE: SKS) and Eli Lilly & Co. (NYSE: LLY). Full research reports are available to readers at:

Economic fundamentals leading into 2012 have set a generally positive pace with GDP growth likely to pick up through the coming year. However, there are several important caveats to note as the world economy continues to face headwinds and risks weigh to the downside. Positive outlooks are conditional on fiscal policy in payroll taxes and unemployment insurance benefits and upon the easing of the European debt situation. A repeat of volatility experienced in 2011 is likely in 2012, as perceptions about the strength of the U.S. economy and the euro zone will vary over time as events unfold.

Despite the current situation, our team continues to identify high momentum situations with growth potential -- there remains strong opportunity within careful discretion.

Equity Leader has decided to cover Saks Inc for its current position within the services industry. Saks Incorporated is a fashion retail company offering an assortment of luxury fashion apparel, shoes, accessories, jewelry, cosmetics, and gifts. The Company is primarily focused on the luxury retail sector. The Company's subsidiaries include Saks Fifth Avenue (SFA), Saks Fifth Avenue OFF 5TH (OFF 5TH), and SFA's e-commerce operations (Saks Direct). A copy of this report detailing Saks Inc (NYSE: SKS) is available at:

Equity Leader is also taking note of Eli Lilly & Co. for its changing role within the healthcare industry. Eli Lilly and Company discovers, develops, manufactures and sells products in one business segment, pharmaceutical products. It also has an animal health business segment. The Company manufactures and distributes its products through facilities in the United States, Puerto Rico, and 17 other countries. Its products are sold in approximately 125 countries. To download free research on Eli Lilly & Co. (NYSE: LLY) investors may visit:

About Equity Leader
Whether you are a first time investor or seasoned market professional, Equity Leader provides the resources necessary to simplify your research process. Our focus has always been to empower investors with the information they need to make their own investment decisions.

Contact Information